Moehs Group, a reference company in the production of pharmaceutical active ingredients.
01 1Coprima SL
02 1Moehs Catalana SL
03 1COSMA Spa
04 1DARMERICA, LLC
05 2Ipca Laboratories Limited
06 1KALCHEM INTERNATIONAL INC
07 1LETCO MEDICAL, LLC
08 1MINSHENG GROUP SHAOXING PHARMACEUTICAL CO., LTD.
09 1Medisca Inc.
10 1Megafine Pharma (P) Limited
11 1Professional Compounding Centers of America
12 1UQUIFA Mexico, S.A. DE C.V.
01 4PYRANTEL PAMOATE
02 9Pyrantel Pamoate
01 1China
02 3India
03 1Italy
04 3Spain
05 4U.S.A
06 1United Kingdom
Moehs Group, a reference company in the production of pharmaceutical active ingredients.
NDC Package Code : 52932-0714
Start Marketing Date : 2009-09-29
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Moehs Group, a reference company in the production of pharmaceutical active ingredients.
NDC Package Code : 68294-0008
Start Marketing Date : 2021-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51604-0013
Start Marketing Date : 2009-10-14
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 57451-0004
Start Marketing Date : 2012-04-12
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 57451-1113
Start Marketing Date : 2012-03-26
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 38779-0059
Start Marketing Date : 2014-06-17
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 22665-0002
Start Marketing Date : 2010-07-19
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 13371-414
Start Marketing Date : 2014-05-14
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51927-0235
Start Marketing Date : 2022-03-04
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 52286-0019
Start Marketing Date : 2009-11-04
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Pyrantel Pamoate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Pyrantel Pamoate, including repackagers and relabelers. The FDA regulates Pyrantel Pamoate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Pyrantel Pamoate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Pyrantel Pamoate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Pyrantel Pamoate supplier is an individual or a company that provides Pyrantel Pamoate active pharmaceutical ingredient (API) or Pyrantel Pamoate finished formulations upon request. The Pyrantel Pamoate suppliers may include Pyrantel Pamoate API manufacturers, exporters, distributors and traders.
click here to find a list of Pyrantel Pamoate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Pyrantel Pamoate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Pyrantel Pamoate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Pyrantel Pamoate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Pyrantel Pamoate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Pyrantel Pamoate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Pyrantel Pamoate suppliers with NDC on PharmaCompass.
We have 11 companies offering Pyrantel Pamoate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
